Dipartimento di Scienza e Tecnologia del Farmaco, via Pietro Giuria 9, Turin, Italy.
J Microencapsul. 2009 Aug;26(5):394-402. doi: 10.1080/02652040802390156.
A method to produce solid lipid nanoparticles (SLN) from W/O/W multiple emulsions was developed applying the solvent-in-water emulsion-diffusion technique. Insulin was chosen as hydrophilic peptide drug to be dissolved in the acidic inner aqueous phase of multiple emulsions and to be consequently carried in SLN. Several partially water-miscible solvents with low toxicity were screened in order to optimize emulsions and SLN composition, after assessing that insulin did not undergo any chemical modification in the presence of the different solvents and under the production process conditions. SLN of spherical shape and with mean diameters in the 600-1200 nm range were obtained by simple water dilution of the W/O/W emulsion. Best results, in terms of SLN mean diameter and encapsulation efficiencies, were obtained using glyceryl monostearate as lipid matrix, butyl lactate as a solvent, and soy lecithin and Pluronic F68 as surfactants. Encapsulation efficiencies up to 40% of the loaded amount were obtained, owing to the actual multiplicity of the system; the use of multiple emulsion-derived SLN can be considered a useful strategy to encapsulate a hydrophilic drug in a lipid matrix.
一种从 W/O/W 复乳中制备固体脂质纳米粒(SLN)的方法是应用溶剂注入-水乳液扩散技术开发的。选择胰岛素作为亲水性肽类药物,溶解在复乳的酸性内水相中,随后被包裹在 SLN 中。筛选了几种低毒性的部分水溶性溶剂,以优化乳液和 SLN 的组成,评估结果表明,在不同溶剂存在的情况下和在生产工艺条件下,胰岛素没有发生任何化学修饰。通过简单地将 W/O/W 乳液稀释,可获得球形且平均粒径在 600-1200nm 范围内的 SLN。使用单硬脂酸甘油酯作为脂质基质、丁内酯作为溶剂、大豆卵磷脂和泊洛沙姆 F68 作为表面活性剂时,可获得最佳的 SLN 平均粒径和包封效率。由于该系统的实际多重性,可获得高达 40%载药量的包封效率;使用复乳衍生的 SLN 可以被认为是将亲水性药物包封在脂质基质中的一种有效策略。